1613465-80-7Relevant academic research and scientific papers
Development of (E)-2-((1,4-Dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-Amidinophenylbenzamides as Potent Inhibitors of Venezuelan Equine Encephalitis Virus
Schroeder, Chad E.,Yao, Tuanli,Sotsky, Julie,Smith, Robert A.,Roy, Sudeshna,Chu, Yong-Kyu,Guo, Haixun,Tower, Nichole A.,Noah, James W.,McKellip, Sara,Sosa, Melinda,Rasmussen, Lynn,Smith, Layton H.,White, E. Lucile,Aubé, Jeffrey,Jonsson, Colleen B.,Chung, Donghoon,Golden, Jennifer E.
supporting information, p. 8608 - 8621 (2014/12/11)
Venezuelan equine encephalitis virus (VEEV) is an emerging pathogenic alphavirus that can cause significant disease in humans. Given the absence of therapeutic options available and the significance of VEEV as a weaponized agent, an optimization effort wa
6-SUBSTITUTED QUINAZOLINONE INHIBITORS
-
Paragraph 0142, (2014/07/07)
The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for exa
